The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Reporting owner

Lynx1 Capital Management LP

Reporting owner CIK 0001910456 · 10% owner

View SEC filings ↗

These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.

Reset

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Nichols WestonNichols WestonLynx1 Capital Management LPLynx1 Capital Management LPNichols Weston · December 23, 2025 · Purchase · Common StockLynx1 Capital Management LP · December 23, 2025 · Purchase · Common StockNichols Weston · December 22, 2025 · Purchase · Common StockLynx1 Capital Management LP · December 22, 2025 · Purchase · Common StockNichols Weston · December 19, 2025 · Purchase · Common stock, $0.0001 par value per share ("Common Stock")Lynx1 Capital Management LP · December 19, 2025 · Purchase · Common stock, $0.0001 par value per share ("Common Stock")Nichols Weston · October 28, 2025 · Purchase · Common stock, $0.0001 par value per shareLynx1 Capital Management LP · October 28, 2025 · Purchase · Common stock, $0.0001 par value per shareNichols Weston · October 21, 2025 · Purchase · Common stock, $0.00001 par value per shareLynx1 Capital Management LP · October 21, 2025 · Purchase · Common stock, $0.00001 par value per shareNichols Weston · October 17, 2025 · Purchase · Common StockLynx1 Capital Management LP · October 17, 2025 · Purchase · Common StockNichols Weston · October 16, 2025 · Purchase · Common StockLynx1 Capital Management LP · October 16, 2025 · Purchase · Common StockNichols Weston · October 15, 2025 · Purchase · Common StockLynx1 Capital Management LP · October 15, 2025 · Purchase · Common StockNichols Weston · October 14, 2025 · Purchase · Common stock, $0.0001 par value per share ("Common Stock")Lynx1 Capital Management LP · October 14, 2025 · Purchase · Common stock, $0.0001 par value per share ("Common Stock")Oct 14, 2025Dec 23, 2025
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

9 dated transactions · 2 of 2 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Dec 23, 2025TScan Therapeutics, Inc.Common StockNichols Weston · Lynx1 Capital Management LPPurchase
Dec 22, 2025TScan Therapeutics, Inc.Common StockNichols Weston · Lynx1 Capital Management LPPurchase
Dec 19, 2025TScan Therapeutics, Inc.Common stock, $0.0001 par value per share ("Common Stock")Nichols Weston · Lynx1 Capital Management LPPurchase
Oct 28, 2025Cullinan Therapeutics, Inc.Common stock, $0.0001 par value per shareNichols Weston · Lynx1 Capital Management LPPurchase
Oct 21, 2025Neuphoria Therapeutics Inc.Common stock, $0.00001 par value per shareNichols Weston · Lynx1 Capital Management LPPurchase
Oct 17, 2025Cullinan Therapeutics, Inc.Common StockNichols Weston · Lynx1 Capital Management LPPurchase
Oct 16, 2025Cullinan Therapeutics, Inc.Common StockNichols Weston · Lynx1 Capital Management LPPurchase
Oct 15, 2025Cullinan Therapeutics, Inc.Common StockNichols Weston · Lynx1 Capital Management LPPurchase
Oct 14, 2025Cullinan Therapeutics, Inc.Common stock, $0.0001 par value per share ("Common Stock")Nichols Weston · Lynx1 Capital Management LPPurchase

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transactions in associated filings

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedCompanyReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: TScan Therapeutics, Inc.TCRX · company listings
Lynx1 Capital Management LP10% owner
Joint filing · amounts unallocated		PurchaseCommon StockNon-derivative security · Code P6,2320.8989 *Value: 5,601.9448Currency not specifiedView ↗
Trade: TScan Therapeutics, Inc.TCRX · company listings
Lynx1 Capital Management LP10% owner
Joint filing · amounts unallocated		PurchaseCommon StockNon-derivative security · Code P75,5000.9Value: 67,950Currency not specifiedView ↗
Trade: TScan Therapeutics, Inc.TCRX · company listings
Lynx1 Capital Management LP10% owner
Joint filing · amounts unallocated		PurchaseCommon stock, $0.0001 par value per share ("Common Stock")Non-derivative security · Code P80,0690.8989 *Value: 71,974.0241Currency not specifiedView ↗
Trade: Cullinan Therapeutics, Inc.CGEM · company listings
Lynx1 Capital Management LP10% owner
Joint filing · amounts unallocated		PurchaseCommon stock, $0.0001 par value per shareNon-derivative security · Code P165,6678.4005 *Value: 1,391,685.6335Currency not specifiedView ↗
Trade: Neuphoria Therapeutics Inc.NEUP · company listings
Lynx1 Capital Management LP10% owner
Joint filing · amounts unallocated		PurchaseCommon stock, $0.00001 par value per shareNon-derivative security · Code P639,1105.137 *Value: 3,283,108.07Currency not specifiedView ↗
Trade: Cullinan Therapeutics, Inc.CGEM · company listings
Lynx1 Capital Management LP10% owner
Joint filing · amounts unallocated		PurchaseCommon StockNon-derivative security · Code P32,2177.8395 *Value: 252,565.1715Currency not specifiedView ↗
Trade: Cullinan Therapeutics, Inc.CGEM · company listings
Lynx1 Capital Management LP10% owner
Joint filing · amounts unallocated		PurchaseCommon StockNon-derivative security · Code P150,0008.855 *Value: 1,328,250Currency not specifiedView ↗
Trade: Cullinan Therapeutics, Inc.CGEM · company listings
Lynx1 Capital Management LP10% owner
Joint filing · amounts unallocated		PurchaseCommon StockNon-derivative security · Code P51,5007.9427 *Value: 409,049.05Currency not specifiedView ↗
Trade: Cullinan Therapeutics, Inc.CGEM · company listings
Lynx1 Capital Management LP10% owner
Joint filing · amounts unallocated		PurchaseCommon stock, $0.0001 par value per share ("Common Stock")Non-derivative security · Code P15,0327.587 *Value: 114,047.784Currency not specifiedView ↗